<?xml version="1.0" encoding="UTF-8"?>
<p>Other IL-6 inhibitors are being tested to treat COVID-19, including sarilumab and siltuximab. The latter showed a decrease in inflammatory markers in a study of 21 COVID-19 patients (not peer-reviewed) (
 <xref rid="B104" ref-type="bibr">104</xref>).
</p>
